Understanding disparities and barriers associated with pediatric transplant evaluation and time to listing: Moving

Elizabeth Steinberg Christofferson1,2,3, Elizabeth B Ruzicka3, Matthew Bolt4

  • 1Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Pediatric Transplantation
|November 5, 2021
PubMed

Insights

Delays in pediatric transplant listing are linked to social, administrative, and financial barriers. Addressing these issues, especially for liver transplant candidates, can reduce wait times and improve outcomes.

Area of Science:

  • Pediatric Transplant Medicine
  • Health Disparities Research
  • Health Services Research

Background:

  • Delayed time to listing (TTL) in pediatric transplant candidates increases mortality and morbidity risks.
  • Existing research has not fully examined the spectrum of health disparities and barriers contributing to delayed transplant listing.
  • Understanding these barriers is crucial for improving the evaluation process for pediatric transplant candidates.

Purpose of the Study:

  • To examine sociodemographic factors and barriers associated with delayed time to listing (TTL) in pediatric transplant candidates.
  • To identify mechanisms explaining differences in TTL among pediatric kidney, liver, and heart transplant candidates.
  • To inform interventions aimed at reducing delays in the pediatric transplant candidate evaluation process.

Main Methods:

  • Retrospective chart reviews of 183 pediatric transplant candidates (ages 0-18) evaluated between 2012-2015.
  • Data collection included demographic information and potential barriers (social, medical, financial, caregiver-related).
  • Statistical analyses included descriptive statistics, logistic regression, Cox proportional hazards models, and path analysis to model TTL.

Main Results:

  • Financial barriers (71.6%) were most common, followed by caregiver psychological/substance use issues (57.9%) and medical problems (49.7%).
  • Older age, kidney/liver organ type, and social, medical, administrative, and financial barriers were directly associated with longer TTL.
  • Public insurance and organ type were indirectly linked to longer TTL through various mediating barriers.

Conclusions:

  • Social, administrative, and financial issues significantly mediate delays in transplant listing, particularly for liver transplant candidates and those with public insurance.
  • Interventions targeting these multifaceted barriers are necessary to reduce TTL and improve outcomes for pediatric transplant candidates.
  • Addressing co-occurring barriers is essential for optimizing the transplant evaluation pathway.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
80
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
95
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
563
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
23
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
587
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
101